When the first cases of a mysterious pneumonia appeared in Wuhan, China, in late 2019, few people imagined that the virus would transform everyday life across the globe. Within months, hospitals were overwhelmed, international borders closed, economies slowed, and billions of people experienced unprecedented lockdowns.
Scientists quickly identified the virus as SARS-CoV-2, while the disease became known as COVID-19. In March 2020, the World Health Organization officially declared the outbreak a global pandemic.
France and the Early Response
France confirmed its first COVID-19 cases in January 2020. As infections increased, hospitals admitted growing numbers of patients with severe respiratory illness.
The country introduced emergency public health measures, including nationwide lockdowns, travel restrictions, mandatory face masks, and social distancing policies aimed at slowing transmission.
The Fastest Vaccine Development in History
Developing vaccines normally takes many years, but COVID-19 changed that timeline dramatically.
Researchers built upon decades of previous work involving coronaviruses and mRNA technology. Governments invested billions of dollars while pharmaceutical companies collaborated internationally.
Instead of skipping safety steps, many clinical trial phases were conducted simultaneously, allowing vaccines to become available much faster.
Different Types of COVID-19 Vaccines
mRNA Vaccines
Vaccines developed by Pfizer-BioNTech and Moderna use messenger RNA to teach the immune system how to recognize the coronavirus spike protein without exposing people to the virus itself.
Importantly, mRNA does not enter the cell nucleus and does not alter human DNA.
Viral Vector Vaccines
Vaccines such as Oxford-AstraZeneca and Johnson & Johnson use a harmless adenovirus to deliver genetic instructions that help the immune system build protection.
